162 related articles for article (PubMed ID: 25197521)
1. Methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Sotoudehmanesh R; Anvari B; Akhlaghi M; Shahraeeni S; Kolahdoozan S
Middle East J Dig Dis; 2010 Sep; 2(2):104-9. PubMed ID: 25197521
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate Hepatotoxicity in Rheumatoid Arthritis: An Analysis of the Physicians' Policy.
Anvari B
Curr Rheumatol Rev; 2020; 16(1):67-73. PubMed ID: 31244428
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis.
Sakthiswary R; Chan GY; Koh ET; Leong KP; Thong BY
ScientificWorldJournal; 2014; 2014():823763. PubMed ID: 24971392
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
[TBL] [Abstract][Full Text] [Related]
7. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.
Varatharajan N; Lim IG; Anandacoomarasamy A; Russo R; Byth K; Spencer DG; Manolios N; Howe GB
Intern Med J; 2009 Apr; 39(4):228-36. PubMed ID: 19402861
[TBL] [Abstract][Full Text] [Related]
9. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
13. [Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].
La Montagna G; Tirri R; Vitello R; Malesci D; Buono R; Mennillo G; Valentini G
Reumatismo; 2006; 58(4):261-7. PubMed ID: 17216014
[TBL] [Abstract][Full Text] [Related]
14. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).
Dhir V; Sandhu A; Kaur J; Pinto B; Kumar P; Kaur P; Gupta N; Sood A; Sharma A; Sharma S
Arthritis Res Ther; 2015 Jun; 17(1):156. PubMed ID: 26063325
[TBL] [Abstract][Full Text] [Related]
16. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Vitamin E in Methotrexate-Induced Hepatotoxicity in Rheumatoid Arthritis: An Open-Label Case-Control Study.
Vaidya B; Bhochhibhoya M; Nakarmi S
Int J Rheumatol; 2020; 2020():5723485. PubMed ID: 32411250
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
Gilani ST; Khan DA; Khan FA; Ahmed M
J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
[TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
